Background Anaplastic thyroid cancer (ATC) represents a rare, aggressive malignancy. We
analyzed factors predictive for overall survival (OS) and treatment modality utilization …

Abstract Purpose of Review Anaplastic thyroid carcinoma is a type of thyroid carcinoma with
the most aggressive biological behaviour amongst thyroid cancer. Here, we review the …

Background: Anaplastic thyroid carcinoma (ATC) is a malignancy with one of the highest
fatality rates. Here we report a retrospective study of the treatment and other factors …

Anaplastic thyroid carcinoma is one of the most aggressive malignancies, with a poor
prognosis. Although rare, representing only 2% of clinically recognized thyroid cancers, the …

Background: Historical outcomes in anaplastic thyroid carcinoma (ATC) are poor, with a
median survival of only 5 months and< 20% of patients surviving 1 year from diagnosis. We …

Anaplastic thyroid cancer (ATC) is an extremely aggressive but rare form of thyroid
malignancy, making up only 1% to 2% of all thyroid cancers. 1 Although the incidence of …

AbstrAct thyroid nodules are common in clinical practice. they may be solitary within a
“normal” thyroid gland or dominant within a multinodular goiter. the incidence of thyroid …

Background Anaplastic thyroid cancer is a rare and aggressive cancer with no standard
radiotherapy-based local treatment. Based on data suggesting synergy between pazopanib …

Objectives: Anaplastic thyroid carcinoma is associated with a high rate of local recurrence
and poor prognosis. This analysis examines the effects of surgery and radiotherapy on …

Anaplastic thyroid carcinoma is one of the most aggressive and deadly cancers in humans
and accounts for one to two cases per million persons annually. The rarity of this malignancy …